GTx, Inc. (Nasdaq: GTXI) announced the initiation of its Phase 2 clinical trial to treat postmenopausal women with stress urinary ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE